A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population (original) (raw)

Nature Genetics volume 38, pages 921–925 (2006)Cite this article

Abstract

Inflammation is now considered critical in the pathogenesis of myocardial infarction. One of the mechanisms regulating the inflammatory process is the ubiquitin-proteasome system. We investigated whether variants of the 20S proteasome are associated with susceptibility to myocardial infarction and found a common SNP (minor allele frequency of 0.35) in the proteasome subunit α type 6 gene (PSMA6) conferring risk of myocardial infarction in the Japanese population (χ2 = 21.1, P = 0.0000044, 2,592 affected individuals versus 2,851 controls). We replicated this association in another panel of myocardial infarction and control subjects, although its relevance to other ethnic groups remains to be clarified. The SNP, located in the 5′ untranslated region of exon 1 in this gene, enhanced the transcription of PSMA6. Moreover, suppression of PSMA6 expression using short interfering RNA in cultured cells reduced activation of the transcription factor NF-κB by stabilizing phosphorylated IκB. Our results implicate this PSMA6 SNP as a previously unknown genetic risk factor for myocardial infarction.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
    Article CAS Google Scholar
  2. Yamada, Y. et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347, 1916–1923 (2002).
    Article CAS Google Scholar
  3. Ozaki, K. et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650–654 (2002).
    Article CAS Google Scholar
  4. Wang, L., Fan, C., Topol, S.E., Topol, E.J. & Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578–1581 (2003).
    Article CAS Google Scholar
  5. Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233–239 (2004).
    Article CAS Google Scholar
  6. Ozaki, K. et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429, 72–75 (2004).
    Article CAS Google Scholar
  7. Cipollone, F. et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. J. Am. Med. Assoc. 291, 2221–2228 (2004).
    Article CAS Google Scholar
  8. Pajukanta, P. et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67, 1481–1493 (2000).
    Article CAS Google Scholar
  9. Broeckel, U. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210–214 (2002).
    Article CAS Google Scholar
  10. Harrap, S.B. et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22, 874–878 (2002).
    Article CAS Google Scholar
  11. Wang, Q. et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34–36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74, 262–271 (2004).
    Article CAS Google Scholar
  12. Hauser, E.R. et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75, 436–447 (2004).
    Article CAS Google Scholar
  13. Samani, N.J. et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77, 1011–1020 (2005).
    Article Google Scholar
  14. Karin, M. & Delhase, M. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol. 12, 85–98 (2000).
    Article CAS Google Scholar
  15. Maki, C.G., Huibregtse, J.M. & Howley, P.M. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56, 2649–2654 (1996).
    CAS PubMed Google Scholar
  16. Salghetti, S.E., Kim, S.Y., & Tansey, W P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717–726 (1999).
    Article CAS Google Scholar
  17. Dimmeler, S., Breitschopf, K., Haendeler, J. & Zeiher, A.M. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189, 1815–1822 (1999).
    Article CAS Google Scholar
  18. Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
    Article CAS Google Scholar
  19. Beinke, S. & Ley, S.C. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem. J. 382, 393–409 (2004).
    Article CAS Google Scholar
  20. Coux, O., Tanaka, K. & Goldberg, A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–847 (1996).
    Article CAS Google Scholar
  21. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
  22. Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. & Tanaka, T Gene-based SNP discover as part of the Japanese Millennium Genome project: identification of 190,562 genetic variations in the human genome. J. Hum. Genet. 47, 605–610 (2002).
    Article CAS Google Scholar
  23. Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388–393 (2004).
    Article CAS Google Scholar
  24. Lo, H.S. et al. Allelic variation in gene expression is common in the human genome. Genome Res. 13, 1855–1862 (2003).
    Article CAS Google Scholar
  25. Herrmann, J., Ciechanover, A., Lerman, L.O. & Lerman, A. The ubiquitin-proteasome system in cardiovascular diseases—a hypothesis extended. Cardiovasc. Res. 61, 11–21 (2004).
    Article CAS Google Scholar
  26. Meiners, S. et al. Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 105, 483–489 (2002).
    Article CAS Google Scholar
  27. Pye, J. et al. Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 284, H919–H926 (2003).
    Article CAS Google Scholar
  28. Elliott, P.J., Zollner, T.M. & Boehncke, W.H. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 81, 235–245 (2003).
    Article CAS Google Scholar
  29. Pritchard, J.K. & Rosenberg, N.A. Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65, 220–228 (1999).
    Article CAS Google Scholar
  30. den Dunnen, J.T. & Antonarakis, S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 15, 7–12 (2000).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank M. Takahashi, M. Yoshii, S. Abiko, W. Yamanobe, M. Omotezako, Y. Ariji, R. Ohishi, M. Watabe, K. Tabei and S. Manabe for their assistance and A. Suzuki and K. Kobayashi for advice on allele-specific gene expression experiments. We also thank all the other members of SNP Research Center, RIKEN and OACIS for their contribution to the completion of our study. We are also grateful to members of The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was supported in part by grants from the Takeda Science Foundation, the Uehara Science Foundation and the Japanese Millennium Project.

Author information

Authors and Affiliations

  1. Laboratory for Cardiovascular Diseases, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
    Kouichi Ozaki & Toshihiro Tanaka
  2. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
    Hiroshi Sato, Hiroya Mizuno & Masatsugu Hori
  3. Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
    Aritoshi Iida & Yusuke Nakamura
  4. Laboratory for Statistical Analysis, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
    Takahiro Nakamura, Atsushi Takahashi & Naoyuki Kamatani
  5. Laboratory for Bone and Joint Disease, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
    Yoshinari Miyamoto & Shiro Ikegawa
  6. Laboratory for Medical Informatics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan
    Tatsuhiko Tsunoda

Authors

  1. Kouichi Ozaki
  2. Hiroshi Sato
  3. Aritoshi Iida
  4. Hiroya Mizuno
  5. Takahiro Nakamura
  6. Yoshinari Miyamoto
  7. Atsushi Takahashi
  8. Tatsuhiko Tsunoda
  9. Shiro Ikegawa
  10. Naoyuki Kamatani
  11. Masatsugu Hori
  12. Yusuke Nakamura
  13. Toshihiro Tanaka

Contributions

K.O. performed most of the experiments and wrote the manuscript; H.S., H.M., Y.M., S.I. and M.H. managed DNA samples and clinical information; A.I. contributed to SNP discovery; T.N., A.T., T. Tsunoda and N.K. performed the data analyses; Y.N. contributed to SNP discovery and preparation of the manuscript; T. Tanaka supervised this study.

Note: Supplementary information is available on the Nature Genetics website.

Corresponding author

Correspondence toToshihiro Tanaka.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Ozaki, K., Sato, H., Iida, A. et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population.Nat Genet 38, 921–925 (2006). https://doi.org/10.1038/ng1846

Download citation

This article is cited by